Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1979 Sep;64(3):788–797. doi: 10.1172/JCI109525

Mechanism of synergistic cell killing when methotrexate precedes cytosine arabinoside: study of L1210 and human leukemic cells.

E Cadman, F Eiferman
PMCID: PMC372183  PMID: 288743

Abstract

Synergistic killing of L1210 cells occurs when methotrexate (MTX) is administered just before 1-beta-D-arabinofuranosylcytosine (Ara-C). This pehnomenon is dependent upon both the dose and time of exposure to MTX. Such increased killing of cells can be explained by the enhanced intracellular accumulation of Ara-C in cells exposed to MTX. This enhancement of Ara-C entry into cells was only observed when the dose of MTX was high enough (1, 10, and 100 muM) to result in free intracellular nondihydrofolate reductase-bound MTX. At the highest doses of MTX (10 and 100 muM) Ara-C triphosphate was increased eightfold and deoxycytidine triphosphate was decreased by 50%. Therefore, the maximum synergistic cell kill when MTX precedes Ara-C may be the consequence of greater inhibition of DNA polymerase by th;e increased Ara-C triphosphate in the presence of the decreasing natural substrate of this enzyme, deoxycytidine triphosphate. Enhanced Ara-C accumulation after administration of MTX was also observed in human acute myelogenous leukemia cells.

Full text

PDF
788

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Avery T. L., Roberts D. Dose-related synergism of cytosine arabinoside and methotrexate against murine leukemia L1210. Eur J Cancer. 1974 Jul;10(7):425–429. doi: 10.1016/0014-2964(74)90025-5. [DOI] [PubMed] [Google Scholar]
  2. BERTINO J. R., BOOTH B. A., BIEBER A. L., CASHMORE A., SARTORELLI A. C. STUDIES ON THE INHIBITION OF DIHYDROFOLATE REDUCTASE BY THE FOLATE ANTAGONISTS. J Biol Chem. 1964 Feb;239:479–485. [PubMed] [Google Scholar]
  3. Cadman E. C., Dix D. E., Handschumacher R. E. Clinical, biological, and biochemical effect of pyrazofurin. Cancer Res. 1978 Mar;38(3):682–688. [PubMed] [Google Scholar]
  4. Chu M. Y., Fischer G. A. The incorporation of 3H-cytosine arabinoside and its effect on murine leukemic cells (L5178Y). Biochem Pharmacol. 1968 May;17(5):753–767. doi: 10.1016/0006-2952(68)90012-9. [DOI] [PubMed] [Google Scholar]
  5. Durham J. P., Ives D. H. Deoxycytidine kinase. I. Distribution in normal and neoplastic tissues and interrelationships of deoxycytidine and 1-beta-D-arabinofuranosylcytosine phosphorylation. Mol Pharmacol. 1969 Jul;5(4):358–375. [PubMed] [Google Scholar]
  6. Edelstein M., Vietti T., Valeriote F. The enhanced cytotoxicity of combinations of 1-beta-D-arabinofuranosylcytosine and methotrexate. Cancer Res. 1975 Jun;35(6):1555–1558. [PubMed] [Google Scholar]
  7. Fridland A. Effect of methotrexate on deoxyribonucleotide pools and DNA synthesis in human lymphocytic cells. Cancer Res. 1974 Aug;34(8):1883–1888. [PubMed] [Google Scholar]
  8. Furth J. J., Cohen S. S. Inhibition of mammalian DNA polymerase by the 5'-triphosphate of 1-beta-d-arabinofuranosylcytosine and the 5'-triphosphate of 9-beta-d-arabinofuranoxyladenine. Cancer Res. 1968 Oct;28(10):2061–2067. [PubMed] [Google Scholar]
  9. Goldman I. D. The mechanism of action of methotrexate. I. Interaction with a low-affinity intracellular site required for maximum inhibition of deoxyribonucleic acid synthesis in L-cell mouse fibroblasts. Mol Pharmacol. 1974 Mar;10(2):257–274. [PubMed] [Google Scholar]
  10. Graham F. L., Whitmore G. F. Studies in mouse L-cells on the incorporation of 1-beta-D-arabinofuranosylcytosine into DNA and on inhibition of DNA polymerase by 1-beta-D-arabinofuranosylcytosine 5'-triphosphate. Cancer Res. 1970 Nov;30(11):2636–2644. [PubMed] [Google Scholar]
  11. Grindey G. B., Nichol C. A. Interaction of drugs inhibiting different steps in the synthesis of DNA. Cancer Res. 1972 Mar;32(3):527–531. [PubMed] [Google Scholar]
  12. HANDSCHUMACHER R. E., FISCHER G. A. METHODS FOR DETERMINATION OF PERMEABILITY OF CELLS TO DRUGS. Methods Med Res. 1964;10:269–276. [PubMed] [Google Scholar]
  13. Hoovis M. L., Chu M. Y. Enhancement of the antiproliferative action of 1- -D-arabinofuranosylcytosine by methotrexate in murine leukemic cells (L5178Y). Cancer Res. 1973 Mar;33(3):521–525. [PubMed] [Google Scholar]
  14. Kessel D. Some observations on the phosphorylation of cytosine arabinoside. Mol Pharmacol. 1968 Jul;4(4):402–404. [PubMed] [Google Scholar]
  15. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  16. MALEY F., MALEY G. F. On the nature of a sparing effect by thymidine on the utilization of deoxycytidine. Biochemistry. 1962 Sep;1:847–851. doi: 10.1021/bi00911a017. [DOI] [PubMed] [Google Scholar]
  17. Momparler R. L. Effect of cytosine arabinoside 5'-triphosphate on mammalian DNA polymerase. Biochem Biophys Res Commun. 1969 Feb 21;34(4):464–471. doi: 10.1016/0006-291x(69)90405-7. [DOI] [PubMed] [Google Scholar]
  18. Solter A. W., Handschumacher R. E. A rapid quantitative determination of deoxyribonucleoside triphosphates based on the enzymatic synthesis of DNA. Biochim Biophys Acta. 1969 Feb 18;174(2):585–590. doi: 10.1016/0005-2787(69)90288-3. [DOI] [PubMed] [Google Scholar]
  19. Tattersall M. H., Connors T. A., Harrap K. R. Interaction of methotrexate and cytosine arabinoside. Lancet. 1972 Dec 23;2(7791):1378–1379. doi: 10.1016/s0140-6736(72)92835-8. [DOI] [PubMed] [Google Scholar]
  20. Tattersall M. H., Harrap K. R. Changes in the deoxyribonucleoside triphosphate pools of mouse 5178Y lymphoma cells following exposure to methotrexate or 5-fluorouracil. Cancer Res. 1973 Dec;33(12):3086–3090. [PubMed] [Google Scholar]
  21. Tattersall M. H., Harrap K. R. Combination chemotherapy: the antagonism of methotrexate and cytosine arabinoside. Eur J Cancer. 1973 Mar;9(3):229–232. doi: 10.1016/s0014-2964(73)80023-4. [DOI] [PubMed] [Google Scholar]
  22. Tattersall M. H., Jackson R. C., Jackson S. T., Harrap K. R. Factors determining cell sensitivity to methotrexate: studies of folate and deoxyribonucleoside triphosphate pools in five mammalian cell lines. Eur J Cancer. 1974 Dec;10(12):819–826. doi: 10.1016/0014-2964(74)90140-6. [DOI] [PubMed] [Google Scholar]
  23. Yoshida S., Yamada M., Masaki S. Inhibition of DNA polymerase-alpha and -beta of calf thymus by 1-beta-D-arabinofuranosylcytosine-5'-triphosphate. Biochim Biophys Acta. 1977 Jul 15;477(2):144–150. doi: 10.1016/0005-2787(77)90230-1. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES